If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambr Nutri Sci Regulatory News (CNSL)

Share Price Information for Cambr Nutri Sci (CNSL)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.60
Ask:
1.90
Spread: 0.30 (18.75%)
Market Cap: £4.16m
CNSL Live PriceLast checked at - London Stock Exchange

Intraday Cambr Nutri Sci Share Chart

Holding(s) in Company

31 Mar 2026 17:35

RNS Number : 9294Y
Cambridge Nutritional Sciences PLC
31 March 2026
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B1VCP282

Issuer Name

CAMBRIDGE NUTRITIONAL SCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Spreadex LTD

City of registered office (if applicable)

St. Albans

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

30-Mar-2026

6. Date on which Issuer notified

31-Mar-2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

8.126200

6.561100

14.687300

34948533

Position of previous notification (if applicable)

8.021100

7.067400

15.088500

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B1VCP282

19336256

8.126200

Sub Total 8.A

19336256

8.126200%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

CFD/Spread Bet

15612277

6.561100

Sub Total 8.B1

15612277

6.561100%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Lawson Roberts01727 895145Spreadex is an FCA regulated provider of spread betting and CFD trading. Founded in 1999, Spreadex gives both retail and professional traders the opportunity to trade over 10,000 global markets, including UK small caps. For more information see www.spreadex.com/financials.

12. Date of Completion

31-Mar-2026

13. Place Of Completion

United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUAONRNSUOOAR
12
Date   Source Headline
22nd Apr 20267:00 amRNSTrading & Business Update
31st Mar 20265:35 pmRNSHolding(s) in Company
31st Mar 20265:32 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSHalf-year Report
4th Nov 20257:00 amRNSNotice of Results & Investor Presentation
25th Sep 20254:30 pmRNSResult of AGM
28th Aug 20257:00 amRNSNotice of AGM & Annual Report
21st Aug 20257:00 amRNSGrant of Options
19th Aug 20257:00 amRNSFinal Results
31st Jul 20257:00 amRNSNotice of Results & Investor Presentation
10th Jul 20257:00 amRNSDirectorate Change
2nd Jul 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTrading Update
23rd May 20257:00 amRNSResolution on HSE Matter
8th Apr 20257:00 amRNSGrant of Options
1st Apr 20257:00 amRNSAppointment of Chief Executive Officer
21st Mar 202511:33 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSOmega Diagnostics Summons Update
18th Mar 20252:48 pmRNSHolding(s) in Company
6th Feb 20257:00 amRNSDirector/PDMR Shareholding
30th Jan 20259:41 amRNSDirector/PDMR Shareholding
21st Jan 20254:03 pmRNSOmega Diagnostics court summons
16th Jan 20257:00 amRNSSettlement of DHSC Claim
7th Jan 20255:25 pmRNSHolding(s) in Company
7th Jan 20255:20 pmRNSHolding(s) in Company
4th Dec 20241:33 pmRNSHolding(s) in Company
4th Dec 20241:32 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSHalf-year Report
15th Nov 20249:24 amRNSNotice of Results and Investor Presentation
27th Sep 202411:20 amRNSResult of AGM
15th Aug 20243:44 pmRNSPosting of Annual Report and Notice of AGM
13th Aug 20247:00 amRNSDirectorate Change
5th Aug 202410:29 amRNSGrant of Options
25th Jul 20247:00 amRNSFinal Results
10th Jul 20247:00 amRNSNotice of Results
6th Jun 20244:26 pmRNSGrant of Options
24th May 20247:00 amRNSDirectorate Change
22nd Apr 20248:21 amRNSTrading Update and Directorate Change
3rd Apr 20247:00 amRNSQ2 2024 Industry Events Schedule
30th Jan 202412:50 pmRNSIssue of Equity and Total Voting Rights
29th Jan 20247:00 amRNSAppointment of Operations Director
22nd Jan 20247:00 amRNSScientific Educational Webinar and Industry Event
18th Dec 20233:51 pmRNSHolding(s) in Company
4th Dec 20237:00 amRNSScientific Educational Programme expanded
28th Nov 20233:56 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
22nd Nov 202310:59 amRNSHolding(s) in Company
20th Nov 202311:09 amRNSHolding(s) in Company
17th Nov 202312:55 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.